Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renfang DENG"'
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23921- (2024)
EBV positive Diffuse Large B-cell lymphoma, not otherwise specified (EBV+DLBCL-NOS) referred to DLBCL with expression of EBV encoded RNA in tumor nucleus. EBV+DLBCL-NOS patients present with more advanced clinical stages and frequent extranodal invol
Externí odkaz:
https://doaj.org/article/27a40281fefd4d0ca0cd35418fcae072
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 266-273 (2023)
Abstract Background Epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) develops resistance to tyrosine kinase inhibitors (TKIs). Here, we evaluated the efficacy of radiotherapy and continuation of TKIs in patients
Externí odkaz:
https://doaj.org/article/eeb4680e131f452d99c150fb840dc7db
Publikováno v:
Chinese Journal of Lung Cancer, Vol 25, Iss 3, Pp 201-206 (2022)
Lung cancer is the most lethal malignancy around the world and non-small cell lung cancer (NSCLC) accounts for 80% of all cases. Most of the NSCLC patients has “driver gene mutations” and targeted therapy achieved a relatively good efficacy, but
Externí odkaz:
https://doaj.org/article/5708e704e7dd405bb48e08c61158f9e0
Publikováno v:
Cancer Medicine. 12:266-273
Epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) develops resistance to tyrosine kinase inhibitors (TKIs). Here, we evaluated the efficacy of radiotherapy and continuation of TKIs in patients with advanced NSCLC with